NASDAQ: MLECMoolec Science Sa Stock
$3.05+0.03 (+0.99%)
Updated Jun 5, 2023
MLEC Price
$3.05
Fair Value Price
N/A
Market Cap
$114.52M
52 Week Low
$2.60
52 Week High
$42.25
P/E
-1.68x
P/B
9.63x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$53.93M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
0.95
Operating Cash Flow
-$2M
Beta
0.61
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
MLEC Overview
LightJump Acquisition Corporation is a 'blank check' company formed to effect mergers, stock purchases, or similar combinations with one or more businesses. It targets the tech sector. LightJump Acquisition was incorporated in 2020 and is headquartered in Menlo Park, CA.
Zen Score
–
Industry Average (26)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how MLEC scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
MLEC is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
MLEC is poor value based on its book value relative to its share price (9.63x), compared to the US Biotechnology industry average (5.21x)
P/B vs Industry Valuation
MLEC is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more MLEC due diligence checks available for Premium users.
Be the first to know about important MLEC news, forecast changes, insider trades & much more!
MLEC News
Valuation
MLEC price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-1.68x
Industry
11.59x
Market
53.21x
MLEC price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
9.63x
Industry
5.21x
MLEC is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
MLEC's financial health
Profit margin
Revenue
$0.0
Net Income
$0.0
Profit Margin
0%
MLEC's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
Assets to liabilities
Assets
$23.2M
Liabilities
$11.3M
Debt to equity
0.95
MLEC's short-term liabilities ($11.28M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
MLEC's short-term assets ($10.43M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
MLEC's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
N/A
Investing
N/A
Financing
N/A
MLEC's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
MLEC vs Biotech Stocks
Moolec Science Sa Stock FAQ
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.